All data are based on the daily closing price as of November 22, 2024
b
BioNote
377740.KO
3.27 USD
-0.09
-2.68%
Overview
Last close
3.27 usd
Market cap
332.83M usd
52 week high
4.55 usd
52 week low
2.69 usd
Target price
4.06 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
4.9656
Price/Book Value
0.2943
Enterprise Value
50.33M usd
EV/Revenue
0.7072
EV/EBITDA
1.5814
Key financials
Revenue TTM
67.18M usd
Gross Profit TTM
366.05M usd
EBITDA TTM
-24.75M usd
Earnings per Share
N/A usd
Dividend
0.14 usd
Total assets
1.33B usd
Net debt
N/A usd
About
BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.